L&C BIO Largest Shareholder Lee Hwan-chul Reports Pledge Contract Amendment with No Change in Stake
L&C BIO's largest shareholder Lee Hwan-chul reported an amendment to his stock pledge loan agreements as of April 14, 2026.
The amended contracts include four pledge agreements with Korea Securities Finance and Kyobo Securities, covering 2,958,353 shares or 11.91% of total outstanding shares.
The reporting person's shareholding remains unchanged at 6,738,428 shares representing 27.12%, with no new capital raised or share issuance involved.
Total loan amount under these pledges is 27 billion KRW, with interest rates ranging from 4.26% to 4.56%, indicating stable transactions with reputable financial institutions.
This pledge contract amendment appears to be for the largest shareholder's personal financial management and does not directly affect the company's capital structure or control.
[AI Summary]This disclosure involves L&C BIO's largest shareholder Lee Hwan-chul amending stock pledge loan contracts with no change in his stake. Although the pledged shares represent a high 11.91% of total shares, the counterparties are credible institutions like Korea Securities Finance and Kyobo Securities, limiting negative stock price impact.